glp 1 least expensive The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Why are GLP-1 medications so
Description
high: 6 mg
In 2019, with a clear mission to tackle serious diseases, Gilead outlined a long-term plan to advance 10 potential transformative therapies by 2030
these drugs include glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors [13, 14]
Those include Ozempic and its sister drug approved for obesity, Wegovy, which use semaglutide, and Mounjaro and Zepbound, for diabetes and obesity, respectively, which use the active ingredient tirzepatide
GLP-1 treatments approved by the FDA come with a steep wholesale acquisition cost of over $12,000 per year
